Vida Ventures, Llc - Net Worth and Insider Trading
Vida Ventures, Llc Net Worth
The estimated net worth of Vida Ventures, Llc is at least $44 Million dollars as of 2024-09-20. Vida Ventures, Llc is the 10% Owner of Kyverna Therapeutics Inc and owns about 4,777,060 shares of Kyverna Therapeutics Inc (KYTX) stock worth over $33 Million. Vida Ventures, Llc is the 10% Owner of Oyster Point Pharma Inc and owns about 963,468 shares of Oyster Point Pharma Inc (OYST) stock worth over $11 Million. Vida Ventures, Llc is also the 10% Owner of Homology Medicines Inc and owns about 42,825 shares of Homology Medicines Inc (FIXX) stock worth over $40,029. Details can be seen in Vida Ventures, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vida Ventures, Llc has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vida Ventures, Llc
Vida Ventures, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vida Ventures, Llc owns 2 companies in total, including Oyster Point Pharma Inc (OYST) , and Homology Medicines Inc (FIXX) .
Click here to see the complete history of Vida Ventures, Llc’s form 4 insider trades.
Insider Ownership Summary of Vida Ventures, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OYST | Oyster Point Pharma Inc | 2019-11-04 | 10 percent owner |
| FIXX | Homology Medicines Inc | 2018-04-02 | 10 percent owner |
Vida Ventures, Llc Latest Holdings Summary
Vida Ventures, Llc currently owns a total of 3 stocks. Among these stocks, Vida Ventures, Llc owns 4,777,060 shares of Kyverna Therapeutics Inc (KYTX) as of February 12, 2024, with a value of $33 Million and a weighting of 75.37%. Vida Ventures, Llc owns 963,468 shares of Oyster Point Pharma Inc (OYST) as of November 4, 2019, with a value of $11 Million and a weighting of 24.54%. Vida Ventures, Llc also owns 42,825 shares of Homology Medicines Inc (FIXX) as of April 2, 2018, with a value of $40,029 and a weighting of 0.09%.
Latest Holdings of Vida Ventures, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics Inc | 2024-02-12 | 4,777,060 | 6.92 | 33,057,255 |
| OYST | Oyster Point Pharma Inc | 2019-11-04 | 963,468 | 11.17 | 10,761,938 |
| FIXX | Homology Medicines Inc | 2018-04-02 | 42,825 | 0.93 | 40,029 |
Holding Weightings of Vida Ventures, Llc
Vida Ventures, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Vida Ventures, Llc has made a total of 1 transactions in Kyverna Therapeutics Inc (KYTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kyverna Therapeutics Inc is the acquisition of 253,136 shares on February 12, 2024, which cost Vida Ventures, Llc around $6 Million.
According to the SEC Form 4 filings, Vida Ventures, Llc has made a total of 1 transactions in Oyster Point Pharma Inc (OYST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oyster Point Pharma Inc is the acquisition of 185,000 shares on November 4, 2019, which cost Vida Ventures, Llc around $3 Million.
According to the SEC Form 4 filings, Vida Ventures, Llc has made a total of 0 transactions in Homology Medicines Inc (FIXX) over the past 5 years. The most-recent trade in Homology Medicines Inc is the acquisition of 20,833 shares on April 2, 2018, which cost Vida Ventures, Llc around $6 Million.
Insider Trading History of Vida Ventures, Llc
- 1
Vida Ventures, Llc Trading Performance
GuruFocus tracks the stock performance after each of Vida Ventures, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vida Ventures, Llc is 13.2%. GuruFocus also compares Vida Ventures, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vida Ventures, Llc within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vida Ventures, Llc's insider trading performs compared to the benchmark.
Performance of Vida Ventures, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.95 | | | | | |
| Relative Return to S&P 500(%) | 1.87 | | | | | |
Vida Ventures, Llc Ownership Network
Vida Ventures, Llc Owned Company Details
What does Oyster Point Pharma Inc do?
Who are the key executives at Oyster Point Pharma Inc?
Vida Ventures, Llc is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .
Oyster Point Pharma Inc (OYST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oyster Point Pharma Inc Insider Transactions
Vida Ventures, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Vida Ventures, Llc. You might contact Vida Ventures, Llc via mailing address: 40 Broad Street, Suite 201, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
